자궁경부암 진단에 HPV DNA검사의 역할

키워드

참고문헌 (59)

1. "Cytologic Screening History of 249 Patients with Cervical Cancer", 30(6), pp.1198~1206 (1998)
2. "Cancer of the cervix", pp.1037~40
3. "Oncogenic association of specific human papilloma virus types with cervical neoplasia", 79(4), pp.671~7 (1987)
4. "A systemic review of the role of human papillomavirus (HPV) testing within a cervical screening programme: summary and conclusions", 83, pp.561~585 (2000)
5. "Hybrid Capture HPV DNA test as a primary screening tool of cervical cancer", 12(1), pp.31~38 (2001)
6. "Human papilloma viruses and their possible role in squamous cell carcinomas", 78, pp.1~30 (1977)
7. "Structural polypeptides of rabbit", pp.1239~47
8. "Utility of liquid-based cytology for cervical carcinoma screening results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma", 87(2), pp.48~55 (1999)
9. "Evaluation of PAPNET testing as an ancillary tool to clarify the status of the atypical cervical smear", 10(6), pp.564~571 (1997)
10. "The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability", 62(23), pp.7075~7082 (2002)
11. "Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine", 93(4), pp.284~292 (2001)
12. "Strategies against human papillomavirus infection and cervical cancer", 42(4), pp.255~266 (2004)
13. "Human papillomavirus DNA testing for cervical cancer screening in low-resource settings", 92(10), pp.818~825 (2000)
14. "Can human papillomavirus DNA testing substitute for cytology in the detection of high-grade cervical lesions?", 128(3), pp.298~302 (2004)
15. "Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea", 190(3), pp.468~476 (2004)
16. "Do HPV-negative cervical carcinomas exist?", 181, pp.253~254 (1997)
17. "Natural history of Low grade squamous intraepithelial lesion", 5(3), pp.153~158 (2001)
18. "Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia", 87, pp.1365~1371 (1995)
19. "Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type", 37(4), pp.1030~1034 (1999)
20. "Distribution and viral load of type specific HPVs in different cervical lesions as detected by PCR-ELISA", 54(5), pp.377~380 (2001)
21. "Viral load of human papillomavirus and risk of CIN3 or cervical cancer", 360(9328), pp.228~229 (2002)
22. "Epidemiology of cervical cancer--overview", pp.3~23
23. "Host and viral genetics and risk of cervical cancer", 89(2), pp.229~240 (2002)
24. "Genital tract infections, cervical inflammation, and antioxidant nutrients--assessing their roles as human papillomavirus cofactors", pp.29~34 (2003)
25. "Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women", 9(11), pp.1183~1191 (2000)
26. "In situ hybridization detection of single-copy human papillomavirus on isolated cells, using a catalyzed signal amplification system: GenPoint", 24(2), pp.112~116 (2001)
27. "Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm", 65(2), pp.606~12 (1991)
28. "Human papillomavirus is a necessary cause of invasive cervical cancer worldwide", 189(1), pp.12~19 (1999)
29. "Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group", 87(11), pp.796~802 (1995)
30. "Homogeneous sampling accounts for the increased diagnostic accuracy using the ThinPrep Processor", 101(2), pp.215~9 (1994)
31. "Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus", 37(8), pp.2508~2517 (1999)
32. "Polymerase chain reaction-based methods for the detection of human papillomavirus DNA", pp.121~33
33. "Comparative evaluation of first- and second generation Digene Hybrid Capture assays for detection of human papillomavirus associated with high or intermediate risk for cervical cancer", 37, pp.796~797 (1999)
34. "Human papillomavirus and cervical cancer", 16(1), pp.1~17 (2003)
35. "Human papillomavirus DNA testing as an adjunct to cytology in cervical screening programs", 127(8), pp.959~968 (2003)
36. "Management of women who test positive for high-risk types of human papillomavirus: the HART study", 362(9399), pp.1871~1876 (2003)
37. "Triage using HPV-testing in persistent borderline and mildly dyskaryotic smears proposal for new guidelines", 116(1), pp.122~129 (2005)
38. "HPV testing and monitoring of women after treatment of CIN 3 review of the literature and meta-analysis", 59(7), pp.543~553 (2004)
39. "Screening for cancer:future potential", 35, pp.1925~1932 (1999)
40. "Human papillomavirus DNA testing as an adjunct to cytology in cervical screening programs", 127, pp.959~968 (2003)
41. "The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix", 201(4), pp.535~543 (2003)
42. "Papanicolaou smear sensitivity for the detection of adenocarcinoma of the cervix a study of 49 cases", 93(1), pp.8~15 (2001)
43. "Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma", 157(4), pp.1055~1062 (2000)
44. "Atypical Squamous Cells of Undetermined Significance-Low-grade Squamous Intraepithelial Lesion Triage Study Interobserver reproducibility of cervical cytologic and histologic interpretations realistic estimates from the ASCUS-LSIL Triage Study", 285(11), pp.1500~1505 (2001)
45. "Comparison of three management strategies for patients with atypical squamous cells of undetermined significance baseline results from a randomized trial", 93(4), pp.293~299 (2001)
46. "Qualification of ASCUS A comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL Triage Study", 116(3), pp.386~394 (2001)
47. "The clinical significance of the poor correlation of cervical dysplasia and cervical malignancy with referral cytologic results", 181(3), pp.560~566 (1999)
48. "2001 Consensus Guidelines for the management of women with cervical cytological abnormalities", 287(16), pp.2120~2129 (2002)
49. "Atypical glandular cells of undetermined significance (AGUS) cytopathologic features, histopathologic results, and human papillomavirus DNA detection", 30(7), pp.816~825 (1999)
50. "American Society for Colposcopy and Cervical Pathology 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia", 189(1), pp.295~304 (2003)
51. "Persistent intraepithelial neoplasia after excision for cervical intraepithelial neoplasia grade III", 89, pp.419~422 (1997)
52. "Is routine colposcopic assessment necessary following laser ablationof cervical intraepithelial neoplasia? Br J Obstet Gynaecol 1990", pp.175~7
53. "Negative predictive value of human papillomavirus test following conization of the cervix uteri", 82, pp.177~180 (2001)
54. "Persistence of human papillomavirus infection after therapeutic conization for CIN 3 is It an alarm for disease recurrence?", 79, pp.294~299 (2000)
55. "Persistent HPV infection after conization in patients with negative margins" (2005)
56. "HPV testing and monitoring of women after treatment of CIN 3 review of the literature and meta- analysis", 59(7), pp.543~553 (2004)
57. "American Cancer Society guidelines for the early detection of cancer, 2003", 53(1), pp.27~43 (2003)
58. "clinical management guidelines for obstetrician-gynecologists. Number 45, August 2003. Cervical cytology screening", 102(2), pp.417~427 (2003)
59. "Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening", 103, pp.304~309 (2004)

관련 논문AI추천